This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ACADIA Pharmaceuticals Inc (ACAD)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 11.71M 57.90M 6.89M 6.85M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 188.36M 108.55M 31.95M 37.85M
Property, Plant & Equipment, Gross 2.55M 4.78M 6.29M 8.05M
Accumulated Depreciation & Depletion 1.97M 4.73M 6.14M 7.62M
Property, Plant & Equipment, Net 579.00K 42.00K 151.00K 426.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 179.00K 0.00 14.00K 119.00K
Total Non-Current Assets 758.00K 42.00K 165.00K 545.00K
Liabilities & Shareholder Equity
Total Assets 189.12M 108.59M 32.11M 38.39M
Accounts Payable 372.00K 1.38M 1.96M 1.97M
Short Term Debt 0.00 0.00 32.00K 78.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 6.98M 5.95M 6.16M 5.96M
Long Term Debt 0.00 0.00 0.00 32.00K
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 8.00K 17.66M 2.59M 2.72M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 8.00K 17.66M 2.59M 2.75M
Total Liabilities 6.99M 23.61M 8.75M 8.71M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 182.13M 84.98M 23.36M 29.69M
Common Par 9.00K 7.00K 5.00K 4.00K
Additional Paid In Capital 587.74M 452.69M 370.22M 353.28M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -405.67M -367.72M -346.87M -324.11M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 48.00K 4.00K 9.00K 512.00K
Total Capitalization 182.13M 84.98M 23.36M 29.72M
Total Equity 182.13M 84.98M 23.36M 29.69M
Total Liabilities & Stock Equity 189.12M 108.59M 32.11M 38.39M
Total Common Shares Outstanding 91.10M 73.33M 52.90M 39.35M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 85.72M 55.12M 52.18M 38.59M
Diluted Weighted Shares Outstanding 85.72M 55.12M 52.18M 38.72M
Number of Employees 48 26 24 27
Number of Part-Time Employees 0 0 0 0
ACAD News

ACAD ACADIA Pharmaceuticals Inc

Analysts Ratings for ACAD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 5 5 5
Moderate Buy 0 0 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACAD ANALYST REPORT

Brokerage Partners

ACAD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs